MedPath

To study the effect of Nano Haritaki and Haritaki Choorna in Constipation.

Phase 2
Conditions
Health Condition 1: null- Functional constipation
Registration Number
CTRI/2018/04/013398
Lead Sponsor
Maharashtra Arogya Mandals Sumatibhai Shah Ayurved Mahavidyalaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patient having complaint Malavshtambha vis-a-vis functional constipation

2)Patient ready for the study and willing for treatment

3)Patient fulfilling Rome III criteria with symptoms

Criteria fulfilled for the last 3 months with symptom onset at least 6 month prior to diagnosis.

Exclusion Criteria

1)Pregnant and lactating women.

2)K/C/O uncontrolled Diabetes Mellitus, uncontrolled thyroid disorder, Renal failure, Anorectal disorders

3)Medication induced constipation eg. Iron suppliments etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To study the efficacy of Nano Haritaki in constipation by constipation assessment scale. <br/ ><br>2)To study the efficacy of Haritaki in constipation by constipation assessment scale. <br/ ><br>3)To compare the efficacy of Nano Haritaki and Haritaki in constipation by constipation assessment scale.Timepoint: <br/ ><br>1)at baseline, 7th day & 14th day. <br/ ><br>2)at baseline, 7th day & 14th day. <br/ ><br>3)at baseline, 7th day & 14th day.
Secondary Outcome Measures
NameTimeMethod
1)To study the effect of Nano Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. <br/ ><br>2)To study the effect of Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. <br/ ><br>3)To compare the efficacy of Nano Haritaki and Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. <br/ ><br>Timepoint: 1)at baseline, 7th day, 14th day <br/ ><br>2)at baseline, 7th day, 14th day <br/ ><br>3)at baseline, 7th day, 14th day
© Copyright 2025. All Rights Reserved by MedPath